188 related articles for article (PubMed ID: 35449173)
21. The mechanism of action of cyclosporin A and FK506.
Ho S; Clipstone N; Timmermann L; Northrop J; Graef I; Fiorentino D; Nourse J; Crabtree GR
Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S40-5. PubMed ID: 8811062
[TBL] [Abstract][Full Text] [Related]
22. Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations.
Kung L; Halloran PF
Transplantation; 2000 Jul; 70(2):327-35. PubMed ID: 10933159
[TBL] [Abstract][Full Text] [Related]
23. Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension.
Zhang W; Victor RG
Am J Hypertens; 2000 Sep; 13(9):999-1004. PubMed ID: 10981550
[TBL] [Abstract][Full Text] [Related]
24. Modulation of the electrophoretic mobility of the linker for activation of T cells (LAT) by the calcineurin inhibitors CsA and FK506: LAT is a potential substrate for PKC and calcineurin signaling pathways.
Cho CS; Elkahwaji J; Chang Z; Scheunemann TL; Manthei ER; Hamawy MM
Cell Signal; 2003 Jan; 15(1):85-93. PubMed ID: 12401523
[TBL] [Abstract][Full Text] [Related]
25. Differential transcriptional regulation of endothelin-1 by immunosuppressants FK506 and cyclosporin A.
Marsen TA; Weber F; Egink G; Suckau G; Baldamus CA
Fundam Clin Pharmacol; 2000; 14(4):401-8. PubMed ID: 11030448
[TBL] [Abstract][Full Text] [Related]
26. Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus.
Chakkera HA; Kudva Y; Kaplan B
Clin Pharmacol Ther; 2017 Jan; 101(1):114-120. PubMed ID: 27804122
[TBL] [Abstract][Full Text] [Related]
27. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
[TBL] [Abstract][Full Text] [Related]
28. In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicillium marneffei.
Mo D; Li X; Wei L; Sun C; Liang H; Cao C
Mycopathologia; 2014 Oct; 178(3-4):217-20. PubMed ID: 25052248
[TBL] [Abstract][Full Text] [Related]
29. Effects of immunosuppressants, calcineurin inhibition, and blockade of endoplasmic reticulum calcium channels on free fatty acid efflux from the ischemic/reperfused rat cerebral cortex.
Phillis JW; Diaz FG; O'Regan MH; Pilitsis JG
Brain Res; 2002 Dec; 957(1):12-24. PubMed ID: 12443975
[TBL] [Abstract][Full Text] [Related]
30. Regulatory T-Cell Augmentation or Interleukin-17 Inhibition Prevents Calcineurin Inhibitor-Induced Hypertension in Mice.
Chiasson VL; Pakanati AR; Hernandez M; Young KJ; Bounds KR; Mitchell BM
Hypertension; 2017 Jul; 70(1):183-191. PubMed ID: 28584011
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells.
Øzbay LA; Smidt K; Mortensen DM; Carstens J; Jørgensen KA; Rungby J
Br J Pharmacol; 2011 Jan; 162(1):136-46. PubMed ID: 20825407
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer's Disease, Dendritic Spines, and Calcineurin Inhibitors: A New Approach?
O'Neal MA; Stallings NR; Malter JS
ACS Chem Neurosci; 2018 Jun; 9(6):1233-1234. PubMed ID: 29757603
[TBL] [Abstract][Full Text] [Related]
33. Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine.
Silva JD; Taglialatela G; Jupiter DC
J Alzheimers Dis; 2023; 95(2):585-597. PubMed ID: 37574739
[TBL] [Abstract][Full Text] [Related]
34. The calcineurin activity profiles of cyclosporin and tacrolimus are different in stable renal transplant patients.
Koefoed-Nielsen PB; Karamperis N; Højskov C; Poulsen JH; Jørgensen KA
Transpl Int; 2006 Oct; 19(10):821-7. PubMed ID: 16961774
[TBL] [Abstract][Full Text] [Related]
35. Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis.
Rebong RA; Santaella RM; Goldhagen BE; Majka CP; Perfect JR; Steinbach WJ; Afshari NA
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7309-15. PubMed ID: 21849421
[TBL] [Abstract][Full Text] [Related]
36. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
Nielsen FT; Ottosen P; Starklint H; Dieperink H
Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
[TBL] [Abstract][Full Text] [Related]
37. Distinct inhibitory effects of tacrolimus and cyclosporin a on calcineurin phosphatase activity.
Fukudo M; Yano I; Masuda S; Okuda M; Inui K
J Pharmacol Exp Ther; 2005 Feb; 312(2):816-25. PubMed ID: 15383634
[TBL] [Abstract][Full Text] [Related]
38. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.
Onyewu C; Blankenship JR; Del Poeta M; Heitman J
Antimicrob Agents Chemother; 2003 Mar; 47(3):956-64. PubMed ID: 12604527
[TBL] [Abstract][Full Text] [Related]
39. The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line.
Schwaninger M; Blume R; Oetjen E; Knepel W
Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):541-5. PubMed ID: 7509460
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in the mechanism of action of cyclosporine and FK506.
Tocci MJ; Sigal NH
Curr Opin Nephrol Hypertens; 1992 Dec; 1(2):236-42. PubMed ID: 1285380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
